基本信息:
- 专利标题： SARS-COV-2 IMMUNODOMINANT PEPTIDE CONSTRUCTS AND USES THEREOF
- 申请号：PCT/US2021/059050 申请日：2021-11-12
- 公开(公告)号：WO2022104002A2 公开(公告)日：2022-05-19
- 发明人： KULA, Tomasz , MACBEATH, Gavin , FERRETTI, Andrew, P.
- 申请人： TSCAN THERAPEUTICS, INC. , AHS HOSPITAL CORP.
- 申请人地址： 830 Winter Street; 475 South Street
- 专利权人： TSCAN THERAPEUTICS, INC.,AHS HOSPITAL CORP.
- 当前专利权人： TSCAN THERAPEUTICS, INC.,AHS HOSPITAL CORP.
- 当前专利权人地址： 830 Winter Street; 475 South Street
- 代理机构： CHOI, Philip, S. et al.
- 优先权： US63/113,024 2020-11-12
- 主分类号： G01N33/68
- IPC分类号： G01N33/68 ; A61K39/215 ; A61P31/14 ; A61K2039/572 ; A61K2039/70 ; A61K39/12 ; C07K14/005 ; C12N2770/20022 ; C12N2770/20034 ; C12N2840/20 ; C12N2840/203 ; G01N2333/70539 ; G01N2500/04 ; G01N2500/10 ; G01N2800/52 ; G01N33/5091 ; G01N33/56972 ; G01N33/56983
摘要：
Provided herein are methods and compositions for the treatment and/or prevention of COVID-19 through the induction of an immune response against identified SARS-COV- 2 immunodominant peptides.